BeOne Medicines (ONC) Construction in Progress (2016 - 2026)

BeOne Medicines (ONC) has 10 years of Construction in Progress data on file, last reported at $137.4 million in Q1 2026.

• Quarterly Construction in Progress fell 76.7% year-over-year to $137.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.4 million (down 76.7% YoY) and the FY2025 annual result came in at $127.2 million, down 80.56% from the prior year.
• Construction in Progress grew to $137.4 million in Q1 2026 per ONC's latest filing, from $127.2 million in the prior quarter.
• Across five years, Construction in Progress topped out at $863.4 million in Q2 2024 and bottomed at $127.2 million in Q4 2025.
• The 5-year median for Construction in Progress is $430.6 million (2023), against an average of $447.9 million.
• The widest annual swing landed in 2023, when Construction in Progress surged 184.02%; it then sank 80.56% in 2025.
• Tracing ONC's Construction in Progress over 5 years: stood at $293.6 million in 2022, then surged by 152.23% to $740.6 million in 2023, then dropped by 11.69% to $654.0 million in 2024, then slumped by 80.56% to $127.2 million in 2025, then advanced by 8.09% to $137.4 million in 2026.
• Per Business Quant, the three latest ONC Construction in Progress figures stand at $137.4 million (Q1 2026), $127.2 million (Q4 2025), and $129.1 million (Q3 2025).

Peer Comparison